🇺🇸 FDA
Pipeline program

CR-001

CR-001-101

Phase 2 small_molecule active

Quick answer

CR-001 for Locally Advanced / Metastatic Solid Tumors is a Phase 2 program (small_molecule) at CRESCENT BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
CRESCENT BIOPHARMA, INC.
Indication
Locally Advanced / Metastatic Solid Tumors
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials